In vitro studies with colon cancer cell lines, using siRNA, showed that HIPK2 silencing is associated with increased PGE2 biosynthesis that was profoundly suppressed by the cPLA2 inhibitor. Here, HIPK2 is linked to malignant colon neoplasm.